Search In this Thesis
   Search In this Thesis  
العنوان
Molecular Diagnosis of Myotonic Dystrophy Type 1 in Egyptian Patients
المؤلف
Radwan,Hoda Abdallah Ahmed
هيئة الاعداد
باحث / Hoda Abdallah Ahmed Radwan
مشرف / Dalia Helmi Farag
مشرف / Laila Kamal El- Din Effat
مشرف / Eman Saleh El-Hadidi
الموضوع
Management of DM1-
تاريخ النشر
2009
عدد الصفحات
130.p:
اللغة
الإنجليزية
الدرجة
ماجستير
التخصص
الطب
تاريخ الإجازة
1/1/2009
مكان الإجازة
جامعة عين شمس - كلية الطب - Clinical and Chemical Pathology
الفهرس
Only 14 pages are availabe for public view

from 130

from 130

Abstract

Myotonic dystrophy type 1 (DM1) also called dystrophia myotonica is an autosomal dominant disorder that results from expansion of unstable trinucleotide repeats in the 3’untranslated region of the dystrophia myotonica protein kinase (DMPK) gene. It is the most common form of adult onset muscular dystrophy, affecting 1:8000 individuals. It is a slowly progressing, highly variable inherited multisystemic disorder that can manifest at any age from birth to old age. It is characterized by wasting of the muscles, posterior subcapsular cataract, cardiac conduction defects, endocrine abnormalities and myotonia. It is classified into three forms; mild, classic and congenital according to CTG repeats number and age of onset.

DMPK gene is located on the long arm of chromosome 19q13.3. The number of CTG repeats varies greatly among individuals, but the average number in a healthy person is from 5-34, patients with DM1 have over 35 and can have as many as 2000 repeats. In general, the more repeats in the affected range that someone has, the earlier the age of onset of symptoms and the more severe the symptoms.
The gold standard for diagnosing myotonic dystrophy type 1 is molecular diagnosis that detects the size of CTG repeats in DMPK gene. It is also of a great value in the prediction of the severity of the phenotype.

The aim of this work was to implement a molecular diagnostic method for confirmation of myotonic dystrophy type 1 in a sample of Egyptian patients. The study included 80 subjects: 20 cases from families with DM1, 40 primary cataract patients as a potential pool of DMPK mutation and 20 healthy controls.
All subjects were subjected to full clinical and genetic history taking, complete clinical examination, Pedigree analysis (for DM1 patients), electromyographic examination, and serum creatine kinase level assessment.
Molecular analysis of DMPK gene mutation was done by expand Long PCR method and polyacrylamide gel electrophoresis for all subjects included in this study